Abstract 6711: Combinations of belantamab mafodotin with lenalidomide, pomalidomide, bortezomib and/or dexamethasone synergize <i>in vitro</i> and potentiate <i>in vivo</i> anti-tumor activity in multiple myeloma
Authors: Rocio Montes De Oca, Ira Gupta, Chris Shelton
Published: 2020-09-04
DOI:
10.1158/1538-7445.am2020-6711
Source:
Full article
Abstract
Abstract